ProRx LLC recalls Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, N
Recalled September 11, 2024 · FDA recall D-0651-2024 · ProRx
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
37 vials
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility
Product
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01
Manufacturer(s)
ProRx LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →